Boston Scientific Corporation (BSX)
Will Cheaper AI Models Like DeepSeek Become a Boon? 3 Stocks to Watch
As costs related to AI models may come down, as is evident from the cheaper DeepSeek model from China, MedTech companies developing AI-based solutions like SYK, BSX and TEM are likely to gain.
BSX Pre-Q4 Earnings: To Buy or Not to Buy Boston Scientific Stock Now?
Boston Scientific is expected to have registered strong growth in the Asia Pacific in the fourth quarter, led by strength in China and Japan.
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?
Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know
In the closing of the recent trading day, Boston Scientific (BSX) stood at $102.27, denoting a +0.32% change from the preceding trading day.
BSX Stock Rises on Positive Data Announcement at the AF Symposium
Boston Scientific announces favorable study data for its FARAPULSE PFA system and WATCHMAN FLX device at the AF Symposium 2025.
Boston Scientific (BSX) Increases Yet Falls Behind Market: What Investors Need to Know
Boston Scientific (BSX) closed the most recent trading day at $98.66, moving +0.5% from the previous trading session.
M&A Synergies Drive BSX: Is it Worth Buying the Stock Now?
Boston Scientific's recent acquisitions have added numerous products with immense potential.
Boston Scientific Jumps Ahead of Earnings
Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Boston Scientific (BSX) settling at $94.61, representing a -0.28% change from its previous close.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement
Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.
Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal
On Wednesday, Boston Scientific Corporation BSX agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and peripheral artery disease.
